Medical Exoskeleton Market by Component (Hardware, Software), Type (Passive Exoskeletons, Powered Exoskeletons), Technology, Functionality, Structure, Mode of Operation, Application, End-Use - Global Forecast 2025-2032
Description
The Medical Exoskeleton Market was valued at USD 1.66 billion in 2024 and is projected to grow to USD 1.87 billion in 2025, with a CAGR of 13.11%, reaching USD 4.46 billion by 2032.
Setting the Stage for Medical Exoskeleton Advancement with an Insightful Overview of Technological Breakthroughs and Market Drivers
Medical exoskeletons represent the convergence of biomechatronics and advanced materials science, delivering a transformative solution for patients with limited mobility and clinicians seeking augmented support. These sophisticated wearable systems integrate precision actuators, advanced sensor networks and intelligent control software to synchronize with human biomechanics, enabling new paradigms in rehabilitation and mobility enhancement. Recent breakthroughs in microcontroller miniaturization and real-time feedback algorithms have dramatically improved device responsiveness and patient comfort, while developments in lightweight composites and ergonomic design have expanded usability across diverse care environments. As demographic trends point toward an aging global population and rising incidence of neuromuscular disorders, the demand for assistive robotic technologies has intensified, prompting increased investment in clinical validation studies and reimbursement frameworks. In parallel, integration with telehealth platforms and remote monitoring solutions has begun to redefine the continuum of care, bridging hospital settings and home-based therapies. This introduction establishes the foundational context for a detailed exploration of the market’s underlying drivers, technological underpinnings and emerging opportunities shaping the future of medical exoskeleton adoption.
Unraveling the Transformative Shifts Redefining Patient Mobility and Clinician Workflow through Exoskeleton Integration Across Healthcare Settings Worldwide
In recent years, the landscape of medical exoskeleton technology has undergone dramatic transformation fueled by breakthroughs in artificial intelligence, connectivity and materials engineering. Embedded machine learning modules now enable adaptive assistance that tunes output dynamically to a patient’s gait pattern or rehabilitation trajectory, while cloud-based analytics platforms facilitate remote therapy adjustments and predictive maintenance. Concurrently, the shift from rigid metal frameworks to soft exosuit architectures has redefined wearer comfort, enabling extended use in outpatient clinics and homecare programs. Powered exoskeleton systems are increasingly leveraging hybrid actuation strategies-combining electric motors with pneumatic and hydraulic components-to deliver customized force profiles that balance energy efficiency with operational flexibility. Modular design principles and open interface standards have further accelerated time to market by streamlining cross-industry collaboration among device manufacturers and research institutions. Together, these transformative shifts underscore a broader trend toward personalization, connectivity and integration across the continuum of patient care, laying the groundwork for broader adoption and novel application paradigms.
Examining the Cumulative Effects of 2025 United States Trade Tariffs on Medical Exoskeleton Supply Chains and Cost Structures in Clinical Applications
As of 2025, the implementation of targeted United States tariffs on imported medical device components has introduced new complexities in the supply chains supporting exoskeleton production. Critical elements such as precision actuators and advanced sensor modules-frequently sourced from specialized overseas suppliers-became subject to elevated duties, compelling original equipment manufacturers to reevaluate procurement strategies and logistical networks. In response, leading device makers have begun establishing localized assembly hubs and strengthening partnerships with domestic microcontroller and control software developers to preserve continuity of innovation and shield against cost volatility. Healthcare procurement teams have simultaneously engaged in value negotiation with payers and service providers to manage budget impacts without compromising access to next-generation exoskeleton therapies. Industry consortiums and advocacy groups are also campaigning for exemptions on medical robotics components, arguing their unique therapeutic benefit and importance in addressing mobility impairments. These strategic adaptations illustrate the resilience of market participants in navigating evolving trade landscapes and preserving the momentum of clinical adoption for exoskeleton-driven care solutions.
Illuminating Core Segmentation Insights through Component, Type, Technology, Functionality, Structure, Operation Mode, Application, and End Use Perspectives
A multi-dimensional segmentation framework offers critical insights into the medical exoskeleton market by delineating distinct technology and application pathways. From a component perspective, hardware elements encompass precision actuators, microcontrollers and an array of motion-capture sensors, while embedded software modules include control systems and monitoring platforms that drive real-time responsiveness. Differentiation by type reveals a dichotomy between passive devices-relying on mechanical support-and powered exoskeletons that integrate motorized assistance for enhanced load carriage. The choice of technology further expands to electric, hydraulic, mechanical and pneumatic architectures, each presenting unique trade-offs in power density, noise profile and maintenance requirements. Functionality segmentation spans full body solutions through targeted upper and lower body devices, addressing specific patient mobility needs. Structural approaches range from rigid exoskeleton frames to flexible soft exosuits designed to conform to anatomical motion. Operation modes vary across autonomous exoskeletons featuring embedded intelligence, manual-controlled systems guided by clinician inputs, and semi-autonomous assisted platforms that blend both paradigms. Application areas include devices for mobility assistance, diagnostic evaluation, rehabilitation protocols, surgical support and therapeutic recovery in orthopedic and physical therapy contexts. Finally, end-use scenarios involve elderly care facilities, homecare settings, military and defense initiatives, research institutions and sports and fitness environments, reflecting the wide-ranging potential of exoskeleton technologies.
Dissecting Regional Dynamics and Growth Drivers across the Americas, Europe Middle East and Africa, and Asia Pacific Markets for Exoskeleton Technologies
Regional dynamics play a pivotal role in shaping the trajectory of exoskeleton adoption and innovation across three principal markets. In the Americas, early adoption has been propelled by robust investment in veteran rehabilitation programs and supportive insurance reimbursement policies that recognize the long-term cost benefits of enhanced mobility. A vibrant start-up ecosystem in North America collaborates closely with academic research centers to pilot advanced exosuit technologies in clinical environments. Moving to Europe, Middle East and Africa, stringent regulatory frameworks including CE marking and centralized healthcare procurement processes influence device certification timelines and price negotiations. Public healthcare systems in Western Europe are increasingly integrating exoskeleton therapies into standard rehabilitation pathways, while emerging markets in the Gulf region invest in high-impact pilot projects to address the rehabilitation needs of diverse patient populations. Across Asia-Pacific, rapid demographic shifts toward an aging population and rising prevalence of neurological disorders are driving governments to subsidize exoskeleton programs. Southeast Asia and China have witnessed a proliferation of public-private partnerships aimed at local manufacturing and clinical research, positioning the region as a hotbed for scalable, cost-effective solutions that meet the needs of both institutional and homecare settings.
Profiling Key Competitive Players Shaping the Medical Exoskeleton Landscape through Innovation, Strategic Partnerships, and Technology Advancements
The competitive landscape of medical exoskeletons is characterized by a blend of pioneering legacy manufacturers and agile newcomers, each leveraging unique technology strengths and strategic alliances. Industry leaders such as Ekso Bionics and ReWalk Robotics continue to refine actuation and control software to enhance wearer responsiveness and clinical outcome tracking. European innovators Cyberdyne and Ottobock have capitalized on their established rehabilitation expertise, forming partnerships with hospital networks to validate new product iterations. Meanwhile, global engineering powerhouse Parker Hannifin applies its legacy in hydraulic and pneumatic systems to deliver high-precision actuator solutions, and the emergent player Armor Bionics has captured attention with its soft exosuit designs optimized for therapeutic applications. Strategic collaborations between component suppliers and system integrators have accelerated prototyping cycles, while targeted acquisitions have enabled several firms to integrate sensor technology into their robotics platforms. Start-ups focused on surgical assistance and military use cases are forging research alliances with defense agencies and medical institutions, contributing to a rapidly evolving ecosystem. Collectively, these key players drive continuous innovation, scale efficiencies and regulatory compliance efforts that collectively shape market performance.
Driving Growth with Actionable Recommendations for Industry Leaders to Capitalize on Technological Innovations and Evolving Market Ecosystems
Industry leaders seeking to capitalize on the accelerating momentum of medical exoskeleton adoption should prioritize several strategic imperatives. First, investing in modular hardware architectures and open interface standards can foster interoperability with third-party sensors and software, reducing time-to-market and enabling future upgrades. Second, developing collaborative reimbursement frameworks with payers and value-based care organizations will establish clear pathways for coverage, reinforcing the economic viability of exoskeleton therapies. Third, leveraging digital twin and simulation platforms during the design phase can expedite validation, minimize prototyping costs and enhance device safety profiles. Fourth, aligning R&D efforts with clinician training programs and standardized usage protocols will bolster user confidence and streamline integration into existing care pathways. Fifth, establishing localized manufacturing and assembly capabilities near key demand centers can mitigate geopolitical and tariff risks while optimizing supply chain agility. Finally, nurturing partnerships with academic and research institutions to conduct longitudinal clinical studies will generate robust data that underscores therapeutic efficacy and drives broader acceptance among healthcare stakeholders.
Outlining a Robust Research Methodology Combining Primary Interviews and Secondary Data Analysis for Unbiased Exoskeleton Market Insights
This analysis is underpinned by a rigorous research methodology that integrates both primary and secondary data sources to ensure comprehensive and unbiased insights. Primary research included in-depth interviews with rehabilitation clinicians, biomedical engineers, supply chain managers and healthcare procurement executives, capturing firsthand perspectives on device performance, adoption barriers and future needs. Secondary research encompassed an extensive review of peer-reviewed journals, patent registries, regulatory approval databases and trade publications, providing context on technological advancements and market dynamics. A triangulation approach was employed to cross-validate findings and reconcile divergent viewpoints, with statistical techniques applied to detect patterns and trends without overreliance on any single data point. Analysts conducted iterative workshops to refine assumptions, and a structured validation framework ensured consistency in segmentation definitions and thematic conclusions. This mixed-methods strategy affords decision-makers a balanced and actionable understanding of the medical exoskeleton landscape.
Providing a Compelling Conclusion That Synthesizes Insights on Technology, Market Dynamics, and Strategic Imperatives for Exoskeleton Adoption
The medical exoskeleton sector stands at an inflection point where accelerating technological innovation, evolving regulatory regimes and shifting patient care paradigms intersect. Cutting-edge actuator systems, intelligent control software and advanced materials are coalescing to expand use cases across rehabilitation, surgical support and mobility assistance. Meanwhile, dynamic trade policies and regional healthcare funding mechanisms continue to reshape supply chain strategies and market entry considerations. Stakeholders able to navigate the interplay between tariff structures, reimbursement frameworks and segmentation nuances will unlock new avenues for growth and patient impact. As the ecosystem matures, collaborative partnerships among device manufacturers, healthcare providers, payers and research institutions will be paramount in validating clinical outcomes, optimizing cost structures and fostering end-user acceptance. Ultimately, the convergence of these forces will define the trajectory of medical exoskeleton adoption, making this an opportune moment for forward-looking organizations to solidify their strategic position and drive meaningful improvements in mobility and quality of life.
Note: PDF & Excel + Online Access - 1 Year
Setting the Stage for Medical Exoskeleton Advancement with an Insightful Overview of Technological Breakthroughs and Market Drivers
Medical exoskeletons represent the convergence of biomechatronics and advanced materials science, delivering a transformative solution for patients with limited mobility and clinicians seeking augmented support. These sophisticated wearable systems integrate precision actuators, advanced sensor networks and intelligent control software to synchronize with human biomechanics, enabling new paradigms in rehabilitation and mobility enhancement. Recent breakthroughs in microcontroller miniaturization and real-time feedback algorithms have dramatically improved device responsiveness and patient comfort, while developments in lightweight composites and ergonomic design have expanded usability across diverse care environments. As demographic trends point toward an aging global population and rising incidence of neuromuscular disorders, the demand for assistive robotic technologies has intensified, prompting increased investment in clinical validation studies and reimbursement frameworks. In parallel, integration with telehealth platforms and remote monitoring solutions has begun to redefine the continuum of care, bridging hospital settings and home-based therapies. This introduction establishes the foundational context for a detailed exploration of the market’s underlying drivers, technological underpinnings and emerging opportunities shaping the future of medical exoskeleton adoption.
Unraveling the Transformative Shifts Redefining Patient Mobility and Clinician Workflow through Exoskeleton Integration Across Healthcare Settings Worldwide
In recent years, the landscape of medical exoskeleton technology has undergone dramatic transformation fueled by breakthroughs in artificial intelligence, connectivity and materials engineering. Embedded machine learning modules now enable adaptive assistance that tunes output dynamically to a patient’s gait pattern or rehabilitation trajectory, while cloud-based analytics platforms facilitate remote therapy adjustments and predictive maintenance. Concurrently, the shift from rigid metal frameworks to soft exosuit architectures has redefined wearer comfort, enabling extended use in outpatient clinics and homecare programs. Powered exoskeleton systems are increasingly leveraging hybrid actuation strategies-combining electric motors with pneumatic and hydraulic components-to deliver customized force profiles that balance energy efficiency with operational flexibility. Modular design principles and open interface standards have further accelerated time to market by streamlining cross-industry collaboration among device manufacturers and research institutions. Together, these transformative shifts underscore a broader trend toward personalization, connectivity and integration across the continuum of patient care, laying the groundwork for broader adoption and novel application paradigms.
Examining the Cumulative Effects of 2025 United States Trade Tariffs on Medical Exoskeleton Supply Chains and Cost Structures in Clinical Applications
As of 2025, the implementation of targeted United States tariffs on imported medical device components has introduced new complexities in the supply chains supporting exoskeleton production. Critical elements such as precision actuators and advanced sensor modules-frequently sourced from specialized overseas suppliers-became subject to elevated duties, compelling original equipment manufacturers to reevaluate procurement strategies and logistical networks. In response, leading device makers have begun establishing localized assembly hubs and strengthening partnerships with domestic microcontroller and control software developers to preserve continuity of innovation and shield against cost volatility. Healthcare procurement teams have simultaneously engaged in value negotiation with payers and service providers to manage budget impacts without compromising access to next-generation exoskeleton therapies. Industry consortiums and advocacy groups are also campaigning for exemptions on medical robotics components, arguing their unique therapeutic benefit and importance in addressing mobility impairments. These strategic adaptations illustrate the resilience of market participants in navigating evolving trade landscapes and preserving the momentum of clinical adoption for exoskeleton-driven care solutions.
Illuminating Core Segmentation Insights through Component, Type, Technology, Functionality, Structure, Operation Mode, Application, and End Use Perspectives
A multi-dimensional segmentation framework offers critical insights into the medical exoskeleton market by delineating distinct technology and application pathways. From a component perspective, hardware elements encompass precision actuators, microcontrollers and an array of motion-capture sensors, while embedded software modules include control systems and monitoring platforms that drive real-time responsiveness. Differentiation by type reveals a dichotomy between passive devices-relying on mechanical support-and powered exoskeletons that integrate motorized assistance for enhanced load carriage. The choice of technology further expands to electric, hydraulic, mechanical and pneumatic architectures, each presenting unique trade-offs in power density, noise profile and maintenance requirements. Functionality segmentation spans full body solutions through targeted upper and lower body devices, addressing specific patient mobility needs. Structural approaches range from rigid exoskeleton frames to flexible soft exosuits designed to conform to anatomical motion. Operation modes vary across autonomous exoskeletons featuring embedded intelligence, manual-controlled systems guided by clinician inputs, and semi-autonomous assisted platforms that blend both paradigms. Application areas include devices for mobility assistance, diagnostic evaluation, rehabilitation protocols, surgical support and therapeutic recovery in orthopedic and physical therapy contexts. Finally, end-use scenarios involve elderly care facilities, homecare settings, military and defense initiatives, research institutions and sports and fitness environments, reflecting the wide-ranging potential of exoskeleton technologies.
Dissecting Regional Dynamics and Growth Drivers across the Americas, Europe Middle East and Africa, and Asia Pacific Markets for Exoskeleton Technologies
Regional dynamics play a pivotal role in shaping the trajectory of exoskeleton adoption and innovation across three principal markets. In the Americas, early adoption has been propelled by robust investment in veteran rehabilitation programs and supportive insurance reimbursement policies that recognize the long-term cost benefits of enhanced mobility. A vibrant start-up ecosystem in North America collaborates closely with academic research centers to pilot advanced exosuit technologies in clinical environments. Moving to Europe, Middle East and Africa, stringent regulatory frameworks including CE marking and centralized healthcare procurement processes influence device certification timelines and price negotiations. Public healthcare systems in Western Europe are increasingly integrating exoskeleton therapies into standard rehabilitation pathways, while emerging markets in the Gulf region invest in high-impact pilot projects to address the rehabilitation needs of diverse patient populations. Across Asia-Pacific, rapid demographic shifts toward an aging population and rising prevalence of neurological disorders are driving governments to subsidize exoskeleton programs. Southeast Asia and China have witnessed a proliferation of public-private partnerships aimed at local manufacturing and clinical research, positioning the region as a hotbed for scalable, cost-effective solutions that meet the needs of both institutional and homecare settings.
Profiling Key Competitive Players Shaping the Medical Exoskeleton Landscape through Innovation, Strategic Partnerships, and Technology Advancements
The competitive landscape of medical exoskeletons is characterized by a blend of pioneering legacy manufacturers and agile newcomers, each leveraging unique technology strengths and strategic alliances. Industry leaders such as Ekso Bionics and ReWalk Robotics continue to refine actuation and control software to enhance wearer responsiveness and clinical outcome tracking. European innovators Cyberdyne and Ottobock have capitalized on their established rehabilitation expertise, forming partnerships with hospital networks to validate new product iterations. Meanwhile, global engineering powerhouse Parker Hannifin applies its legacy in hydraulic and pneumatic systems to deliver high-precision actuator solutions, and the emergent player Armor Bionics has captured attention with its soft exosuit designs optimized for therapeutic applications. Strategic collaborations between component suppliers and system integrators have accelerated prototyping cycles, while targeted acquisitions have enabled several firms to integrate sensor technology into their robotics platforms. Start-ups focused on surgical assistance and military use cases are forging research alliances with defense agencies and medical institutions, contributing to a rapidly evolving ecosystem. Collectively, these key players drive continuous innovation, scale efficiencies and regulatory compliance efforts that collectively shape market performance.
Driving Growth with Actionable Recommendations for Industry Leaders to Capitalize on Technological Innovations and Evolving Market Ecosystems
Industry leaders seeking to capitalize on the accelerating momentum of medical exoskeleton adoption should prioritize several strategic imperatives. First, investing in modular hardware architectures and open interface standards can foster interoperability with third-party sensors and software, reducing time-to-market and enabling future upgrades. Second, developing collaborative reimbursement frameworks with payers and value-based care organizations will establish clear pathways for coverage, reinforcing the economic viability of exoskeleton therapies. Third, leveraging digital twin and simulation platforms during the design phase can expedite validation, minimize prototyping costs and enhance device safety profiles. Fourth, aligning R&D efforts with clinician training programs and standardized usage protocols will bolster user confidence and streamline integration into existing care pathways. Fifth, establishing localized manufacturing and assembly capabilities near key demand centers can mitigate geopolitical and tariff risks while optimizing supply chain agility. Finally, nurturing partnerships with academic and research institutions to conduct longitudinal clinical studies will generate robust data that underscores therapeutic efficacy and drives broader acceptance among healthcare stakeholders.
Outlining a Robust Research Methodology Combining Primary Interviews and Secondary Data Analysis for Unbiased Exoskeleton Market Insights
This analysis is underpinned by a rigorous research methodology that integrates both primary and secondary data sources to ensure comprehensive and unbiased insights. Primary research included in-depth interviews with rehabilitation clinicians, biomedical engineers, supply chain managers and healthcare procurement executives, capturing firsthand perspectives on device performance, adoption barriers and future needs. Secondary research encompassed an extensive review of peer-reviewed journals, patent registries, regulatory approval databases and trade publications, providing context on technological advancements and market dynamics. A triangulation approach was employed to cross-validate findings and reconcile divergent viewpoints, with statistical techniques applied to detect patterns and trends without overreliance on any single data point. Analysts conducted iterative workshops to refine assumptions, and a structured validation framework ensured consistency in segmentation definitions and thematic conclusions. This mixed-methods strategy affords decision-makers a balanced and actionable understanding of the medical exoskeleton landscape.
Providing a Compelling Conclusion That Synthesizes Insights on Technology, Market Dynamics, and Strategic Imperatives for Exoskeleton Adoption
The medical exoskeleton sector stands at an inflection point where accelerating technological innovation, evolving regulatory regimes and shifting patient care paradigms intersect. Cutting-edge actuator systems, intelligent control software and advanced materials are coalescing to expand use cases across rehabilitation, surgical support and mobility assistance. Meanwhile, dynamic trade policies and regional healthcare funding mechanisms continue to reshape supply chain strategies and market entry considerations. Stakeholders able to navigate the interplay between tariff structures, reimbursement frameworks and segmentation nuances will unlock new avenues for growth and patient impact. As the ecosystem matures, collaborative partnerships among device manufacturers, healthcare providers, payers and research institutions will be paramount in validating clinical outcomes, optimizing cost structures and fostering end-user acceptance. Ultimately, the convergence of these forces will define the trajectory of medical exoskeleton adoption, making this an opportune moment for forward-looking organizations to solidify their strategic position and drive meaningful improvements in mobility and quality of life.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
187 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of artificial intelligence algorithms for adaptive exoskeleton assistance in rehabilitation programs
- 5.2. Adoption of lightweight composite materials and modular designs to enhance patient comfort and mobility in exoskeleton devices
- 5.3. Strategic partnerships between medical exoskeleton startups and major healthcare providers for clinical trial expansion
- 5.4. Emergence of tele-rehabilitation platforms with remote monitoring capabilities in medical exoskeleton treatments
- 5.5. Advancements in battery technology and wireless control systems to extend exoskeleton operational duration in clinical settings
- 5.6. Regulatory approvals and updated reimbursement frameworks driving increased accessibility of medical exoskeleton therapies
- 5.7. Integration of virtual reality environments with exoskeleton systems for immersive neurorehabilitation and patient engagement
- 5.8. Customization of exoskeleton design through 3D scanning and additive manufacturing accelerating patient-specific fit
- 5.9. Expansion of tele-rehabilitation platforms incorporating remote-controlled exoskeleton training for stroke patients
- 5.10. Surge in soft robotic exosuit adoption for elderly mobility support in home healthcare settings
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Medical Exoskeleton Market, by Component
- 8.1. Hardware
- 8.1.1. Actuators
- 8.1.2. Microcontrollers
- 8.1.3. Sensors
- 8.2. Software
- 8.2.1. Control Software
- 8.2.2. Monitoring Software
- 9. Medical Exoskeleton Market, by Type
- 9.1. Passive Exoskeletons
- 9.2. Powered Exoskeletons
- 10. Medical Exoskeleton Market, by Technology
- 10.1. Electric
- 10.2. Hydraulic
- 10.3. Mechanical
- 10.4. Pneumatic
- 11. Medical Exoskeleton Market, by Functionality
- 11.1. Full Body Exoskeletons
- 11.2. Lower Body Exoskeletons
- 11.3. Upper Body Exoskeletons
- 12. Medical Exoskeleton Market, by Structure
- 12.1. Rigid Exoskeletons
- 12.2. Soft Exoskeletons
- 13. Medical Exoskeleton Market, by Mode of Operation
- 13.1. Autonomous Exoskeletons
- 13.2. Manual Controlled
- 13.3. Semi Autonomous/Assisted
- 14. Medical Exoskeleton Market, by Application
- 14.1. Assistive Devices for Mobility
- 14.1.1. Disabled Patients
- 14.1.2. Elderly Assistance
- 14.2. Diagnostic Support
- 14.3. Rehabilitation
- 14.4. Surgical Assistance
- 14.5. Therapeutic Use
- 14.5.1. Orthopedic Recovery
- 14.5.2. Physical Therapy
- 15. Medical Exoskeleton Market, by End-Use
- 15.1. Elderly Care Facilities
- 15.2. Homecare Settings
- 15.3. Military & Defense
- 15.4. Research Institutions & Universities
- 15.5. Sports & Fitness
- 16. Medical Exoskeleton Market, by Region
- 16.1. Americas
- 16.1.1. North America
- 16.1.2. Latin America
- 16.2. Europe, Middle East & Africa
- 16.2.1. Europe
- 16.2.2. Middle East
- 16.2.3. Africa
- 16.3. Asia-Pacific
- 17. Medical Exoskeleton Market, by Group
- 17.1. ASEAN
- 17.2. GCC
- 17.3. European Union
- 17.4. BRICS
- 17.5. G7
- 17.6. NATO
- 18. Medical Exoskeleton Market, by Country
- 18.1. United States
- 18.2. Canada
- 18.3. Mexico
- 18.4. Brazil
- 18.5. United Kingdom
- 18.6. Germany
- 18.7. France
- 18.8. Russia
- 18.9. Italy
- 18.10. Spain
- 18.11. China
- 18.12. India
- 18.13. Japan
- 18.14. Australia
- 18.15. South Korea
- 19. Competitive Landscape
- 19.1. Market Share Analysis, 2024
- 19.2. FPNV Positioning Matrix, 2024
- 19.3. Competitive Analysis
- 19.3.1. B-Temia Inc.
- 19.3.2. Comau S.p.A.
- 19.3.3. Cyberdyne Inc.
- 19.3.4. Ekso Bionics Holdings Inc.
- 19.3.5. ExoAtlet, LLC
- 19.3.6. Focal Meditech BV
- 19.3.7. Honda Motor Co. Ltd.
- 19.3.8. Hyundai Motor Company
- 19.3.9. Levitate Technologies, Inc.
- 19.3.10. Lockheed Martin Corporation
- 19.3.11. Mitsubishi Heavy Industries, Ltd.
- 19.3.12. Myomo, Inc.
- 19.3.13. Ottobock SE & Co. KGaA
- 19.3.14. P&S Mechanics Co., Ltd.
- 19.3.15. Panasonic Holdings Corporation
- 19.3.16. Parker Hannifin Corporation
- 19.3.17. ReWalk Robotics Ltd.
- 19.3.18. Rex Bionics Plc
- 19.3.19. Roam Robotics
- 19.3.20. Toyota Motor Corporation
- 19.3.21. Trexo Robotics, Inc.
- 19.3.22. Wandercraft S.A.S.
- 19.3.23. Yaskawa Electric Corporation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
